137 related articles for article (PubMed ID: 32922598)
1. Use of segmental colorectal lavage cytology during surveillance colonoscopy for detecting dysplastic and cancer cells in patients with ulcerative colitis.
Torii Y; Sano D; Ikeuchi H; Hida N; Hirota S
Int J Clin Exp Pathol; 2020; 13(8):2035-2040. PubMed ID: 32922598
[TBL] [Abstract][Full Text] [Related]
2. Density gradient centrifugation of colonic fluid after segmental lavage: a method of purification of exfoliative epithelial colonic cells for cytological interpretation and image cytometry in patients with long-standing ulcerative colitis.
Keller R; Brandt B; Terpe HJ; Winde G; Foerster EC; Domschke W
Am J Gastroenterol; 1999 Feb; 94(2):404-9. PubMed ID: 10022637
[TBL] [Abstract][Full Text] [Related]
3. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
4. Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity.
Awais D; Siegel CA; Higgins PD
Gut; 2009 Nov; 58(11):1498-503. PubMed ID: 19651634
[TBL] [Abstract][Full Text] [Related]
5. Clinical course of colorectal cancer in patients with ulcerative colitis.
Higashi D; Futami K; Ishibashi Y; Egawa Y; Maekawa T; Matsui T; Iwashita A; Kuroki M
Anticancer Res; 2011 Jul; 31(7):2499-504. PubMed ID: 21873166
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic Diagnosis of Nonpedunculated Dysplasia during Surveillance of Ulcerative Colitis: A Survey-Based Multinational Study.
Yang DH; John S; Mitsuhiro F; Cha JM; Byeon JS; Kim HW; Kim HG; Friedland S; Koh YX; Yoon JY; Kwak MS; Ye BD; Kim J; Yang SK
Gut Liver; 2020 Sep; 14(5):611-618. PubMed ID: 31842526
[TBL] [Abstract][Full Text] [Related]
7. Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial.
Vleugels JLA; Rutter MD; Ragunath K; Rees CJ; Ponsioen CY; Lahiff C; Ket SN; Wanders LK; Samuel S; Butt F; Kuiper T; Travis SPL; D'Haens G; Wang LM; van Eeden S; East JE; Dekker E
Lancet Gastroenterol Hepatol; 2018 May; 3(5):305-316. PubMed ID: 29567006
[TBL] [Abstract][Full Text] [Related]
8. Cytology and image cytometry after colonic lavage: a complementary diagnostic tool in patients with ulcerative colitis.
Keller R; Brandt B; Terpe HJ; Winde G; Foerster EC; Domschke W
Dig Liver Dis; 2003 Jan; 35(1):24-31. PubMed ID: 12725604
[TBL] [Abstract][Full Text] [Related]
9. STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis.
Osone K; Yokobori T; Katayama C; Takahashi R; Kato R; Tatsuski H; Takada T; Yajima R; Motegi Y; Ogawa H; Fujii T; Ojima H; Nakamura J; Yao T; Shirabe K; Kuwano H
Oncol Lett; 2019 Nov; 18(5):4712-4718. PubMed ID: 31611980
[TBL] [Abstract][Full Text] [Related]
10. Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
Leong RW; Ooi M; Corte C; Yau Y; Kermeen M; Katelaris PH; McDonald C; Ngu M
Gastroenterology; 2017 May; 152(6):1337-1344.e3. PubMed ID: 28126349
[TBL] [Abstract][Full Text] [Related]
11. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease.
Subramanian V; Ramappa V; Telakis E; Mannath J; Jawhari AU; Hawkey CJ; Ragunath K
Inflamm Bowel Dis; 2013 Feb; 19(2):350-5. PubMed ID: 22552948
[TBL] [Abstract][Full Text] [Related]
12. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?
Blonski W; Kundu R; Lewis J; Aberra F; Osterman M; Lichtenstein GR
Scand J Gastroenterol; 2008; 43(6):698-703. PubMed ID: 18569987
[TBL] [Abstract][Full Text] [Related]
13. Most dysplasia in ulcerative colitis is visible at colonoscopy.
Rutter MD; Saunders BP; Wilkinson KH; Kamm MA; Williams CB; Forbes A
Gastrointest Endosc; 2004 Sep; 60(3):334-9. PubMed ID: 15332019
[TBL] [Abstract][Full Text] [Related]
14. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Collins PD; Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2006 Apr; (2):CD000279. PubMed ID: 16625534
[TBL] [Abstract][Full Text] [Related]
15. Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance.
Goldstone R; Itzkowitz S; Harpaz N; Ullman T
Inflamm Bowel Dis; 2012 May; 18(5):832-7. PubMed ID: 21739534
[TBL] [Abstract][Full Text] [Related]
16. Ulcerative colitis-associated colorectal cancer.
Yashiro M
World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
[TBL] [Abstract][Full Text] [Related]
17. Detecting dysplasia using white light endoscopy or chromoendoscopy in ulcerative colitis patients without primary sclerosing cholangitis: A systematic review and meta-analysis.
Azizi S; Al-Rubaye H; Turki MAA; Siddiqui MRS; Shanmuganandan AP; Ehsanullah B; Brar R; Abulafi AM
Int J Surg; 2018 Apr; 52():180-188. PubMed ID: 29462738
[TBL] [Abstract][Full Text] [Related]
18. Low prevalence of dysplastic polyps in patients with ulcerative colitis.
Laish I; Shurani A; Barkay O; Konikoff FM; Naftali T
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):204-209. PubMed ID: 27838112
[TBL] [Abstract][Full Text] [Related]
19. Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases.
Ten Hove JR; Mooiweer E; Dekker E; van der Meulen-de Jong AE; Offerhaus GJ; Ponsioen CY; Siersema PD; Oldenburg B
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):222-228.e2. PubMed ID: 27613257
[TBL] [Abstract][Full Text] [Related]
20. A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.
Garrity-Park MM; Loftus EV; Bryant SC; Smyrk TC
Inflamm Bowel Dis; 2016 Jul; 22(7):1568-74. PubMed ID: 27135485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
